Compositions and methods for identifying PKB kinase inhibitors

Details for Australian Patent Application No. 2003200026 (hide)

Owner Onyx Pharmaceuticals, Inc. The Babraham Institute

Inventors Hawkings, Philip; Stephens, Len; Stokoe, David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003200026

Parent 93950

Filing date 2 January 2003

Wipo publication date 10 April 2003

International Classifications

C12N 015/54 Mutation or genetic engineering - Transferases (2)

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 016/40 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

23 January 2003 Complete Application Filed

10 April 2003 Application Open to Public Inspection

  Published as AU-A-2003200026

11 December 2003 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003200027-Adaptive Wavefront Modulation System and Method for Ophthalmic Surgery

2003200025-A fluid management system